Depression, Ptsd, And Anxiety Disorders

28 Questions | Total Attempts: 126

SettingsSettingsSettings
Please wait...
Neurology Quizzes & Trivia

For students. By students.


Questions and Answers
  • 1. 
    Who is more likely due to develop PTSD?
    • A. 

      Men

    • B. 

      Women

  • 2. 
    Which of the following best classifies the symptom of “insomnia”?
    • A. 

      Avoidance Symptoms

    • B. 

      Depressive Symptoms

    • C. 

      Hyperarousal Symptoms

    • D. 

      Re-experiencing Symptoms

  • 3. 
    A patient presents to the ER, is stabilized, and diagnosed with PTSD. Before the patient is discharged or any treatment is began, what should be a clinician’s first option?
    • A. 

      Sertraline

    • B. 

      Paroxetine

    • C. 

      SSRI + atypical antipsychotic titrated to severity

    • D. 

      Venlafaxine ER (Effexor XR)

    • E. 

      Either A or B

    • F. 

      None of the above/Other

  • 4. 
    Which pharmacotherapy treatment option would be considered the best for use in a pregnant patient with OCD?
    • A. 

      Amitriptyline

    • B. 

      Citalopram

    • C. 

      Clomipramine

    • D. 

      Fluoxetine

  • 5. 
    Of the following, which would be the most appropriate treatment consideration for adolescents with OCD?
    • A. 

      CBT + amitriptyline

    • B. 

      CBT + paroxetine

    • C. 

      CBT + sertraline

    • D. 

      None of the above, the risk of suicidality associated with SSRIs is too great in adolescents. CBT should be used alone.

  • 6. 
    Of the following, which SSRIs require lower doses in patients with renal impairment? (check all that apply)
    • A. 

      Citalopram

    • B. 

      Clomipramine

    • C. 

      Fluoxetine

    • D. 

      Fluvoxamine

    • E. 

      Sertraline

  • 7. 
    Duration of treatment: How long should CBT typically last (assuming weekly sessions)? How long should pharmacotherapy be continued?
    • A. 

      8-12 weeks; 4-6 weeks

    • B. 

      13-20 weeks ; 8-12 weeks

  • 8. 
    Which of the following properties regarding BZD is false?
    • A. 

      Are excreted unchanged, primarily through urine

    • B. 

      BZDs are lipophilic leading to increased half-lives in older adults

    • C. 

      Carry a risk of cognitive impairment with long-term use

    • D. 

      Risk associated with withdrawal/rebound symptoms are associated with high doses, but can occur at therapeutic doses as well

  • 9. 
    A patient in the ER manifests a series of violent seizure. Which medication would be best (in terms of kinetics for just this episode of seizures) for this patients?
    • A. 

      Diazepam (Valium ®)

    • B. 

      Clorazepate (Tranzene ®)

    • C. 

      Lorazepam (Ativan ®)

  • 10. 
    Which of the following (regarding the “selected products” section) is False?
    • A. 

      Diazepam has the widest range of indications

    • B. 

      Oxazepam has no active metabolites

    • C. 

      Flumazenil is a competitive agonist of BZD at the BZ receptor

    • D. 

      Zolpidem is a selective BZ1 agonist

  • 11. 
    Which of the following regarding anxiety is False?
    • A. 

      Most common all psychiatric disorder

    • B. 

      More common in men than women

    • C. 

      Can be secondary to medication

    • D. 

      Commonly comorbid with other disease states

  • 12. 
    What FDA  warning comes with citalopram (Celexa ®)?
    • A. 

      Hypotension

    • B. 

      Prolonged QT

    • C. 

      Seizures

    • D. 

      Sudden death

  • 13. 
    In anxiety, benzodiazepines are _____ for patients who cannot tolerate antidepressants and ______ for patients requiring rapid relief of anxiety.
    • A. 

      1st line ; 1st line

    • B. 

      1st line ; 2nd line

    • C. 

      2nd line ; 1st line

    • D. 

      2nd line ; 2nd line

  • 14. 
    Which of the following are Long acting benzodiazepine (4 answers) ?
    • A. 

      Alprazolam

    • B. 

      Chlordiazepoxide

    • C. 

      Lorazepam, Oxazepam, Temazepam

    • D. 

      Triazolam

    • E. 

      Clonazepam

    • F. 

      Diazepam

    • G. 

      Flurazepam

  • 15. 
    When stopping BZD use, patients may to expect symptoms of withdrawal in only the first 1-3 days of stopping therapy.
    • A. 

      True

    • B. 

      False

  • 16. 
    What is the taper recommended for BZD therapy?
    • A. 

      Taper 10% every week

    • B. 

      Taper 25% every week

    • C. 

      Taper 25% over 2-3 weeks

    • D. 

      Taper 50% over 2-3 weeks

  • 17. 
    Mirtazipine is a BZD antagonist that has high affinity for BZD but lacks efficacy--making it useful in BZD overdose
    • A. 

      True

    • B. 

      False

  • 18. 
    All SSRIs are effective for the treatment of panic disorder
    • A. 

      True

    • B. 

      False

  • 19. 
    How long after initiating anti-anxiety therapy with SSRIs does it take to assess a full response?
    • A. 

      2-4 weeks

    • B. 

      6-8 weeks

    • C. 

      10-12 weeks

    • D. 

      12-16 weeks

  • 20. 
    Duoloxetine (Cymbalta ®) is the only SNRI approved for panic disorder
    • A. 

      True

    • B. 

      False

  • 21. 
    Which of the following side effects of MAOi can be exacerbated by diet?
    • A. 

      COPD

    • B. 

      Hypertensive crisis

    • C. 

      Prolonged QT

    • D. 

      Sudden Death

  • 22. 
    Though not commonly used as such, TCA’s (historically and presently) are used PRN for panic attacks
    • A. 

      True

    • B. 

      False

  • 23. 
    Due to their greater efficacy than SSRIs, BZDs are first line treatment in GAD
    • A. 

      True

    • B. 

      False

  • 24. 
    Which of the following, in regards to buspirone (Buspar ®), is True?
    • A. 

      Acts on GABA receptors involved with fear/anxiety

    • B. 

      Are structurally related to BZD, but have completely different mechanism of action

    • C. 

      Have slower onset of effects than BZD

    • D. 

      Have higher abuse potential than BZD

    • E. 

      More convenient dosing schedule

  • 25. 
    Which of the following Does NOT carry and FDA indication for GAD?
    • A. 

      Escitalopram

    • B. 

      Paroxetine

    • C. 

      Venlafaxine ER

    • D. 

      Venlafaxine IR

    • E. 

      Duloxetine

Back to Top Back to top